Buserelin
Also known as: Suprefact, Suprecur
Clinical Status
Approved in Europe and Canada — not FDA approved in US.
Mechanism of Action
A GnRH agonist analog that desensitizes pituitary GnRH receptors with continuous use, leading to suppression of gonadotropin secretion and subsequent reduction in sex steroid levels.
Dosing Defaults
Dose
100-500 mcg
Frequency
3x daily (intranasal) or depot every 2-3 months
Administration
Intranasal, subcutaneous, or depot injection
Timing
Morning, afternoon, evening (intranasal)
Food
with or without
Duration
Per treatment protocol
Dose range: 100-900 mcg daily (intranasal) or depot
Multiple daily doses maintain suppressive levels for intranasal form.
Side Effects
- •Hot flashes
- •Headache
- •Nasal irritation
- •Decreased libido
- •Bone density loss
- •Depression
Contraindications & Warnings
- ⚠Pregnancy
- ⚠Hormone-dependent cancers (initial flare risk)
- •Not medical advice
- •Not FDA approved in the US
Compare
Compare Buserelin with another peptide side-by-side.
Ad
Related Hormonal Peptides
This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.